M. Bernardo

N-Terminal pro-Brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection

F. V. Álvarez, B. Prieto, E. Llorente, 2007, Annals of clinical biochemistry.

Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation.

V. Álvarez, E. Coto, B. Tavira, 2012, Transplantation proceedings.

Effect of Early Conversion to Everolimus Together With Prophylaxis With Valganciclovir in the Prevention of Cytomegalovirus Infection in Heart Transplant Recipients

B. D. Molina, A. G. Campos, M. Bernardo, 2015 .